Clinical Trial Update: Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

View source ↗

Summary

A clinical-trial update describes a study of PNPLA3 genetic variants in patients with MASLD/MASH in Guadeloupe. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe | Conditions: MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) | Status: RECRUITING